
|Videos|July 28, 2016
CINV: Understanding the Guidelines for Recommendations
Advertisement
Episodes in this series

James Natale, PharmD, BCOP, outlines the guidelines for acute and delayed emesis in patients receiving highly emetic chemotherapy versus moderately emetic chemotherapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
4
Apnimed Submits NDA for AD109 Following Positive Phase 3 Results in Obstructive Sleep Apnea
5
















































































































































